| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:22853509:2765 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:22853509:2765?format=raw |
LEADER: 02765cam a2200589 a 4500
001 3580912
005 20221020083401.0
008 931114s1993 dcua b f000 0 eng c
010 $a 93246889
016 7 $a9420473$2DNLM
020 $a0160420962 :$c$4.25
029 1 $aNLM$b9420473
035 $a(OCoLC)ocm29321957
035 $a(NNC)3580912
035 $a3580912
037 $a052-003-01350-9$bGPO
040 $aDGPO/DLC$cDLC$dNLM$dWCL$dCUM$dGPO$dVYL$dVET$dGPO$dMvI$dMvI
043 $an-us---
050 00 $aRC564$b.B57 1993
060 00 $a1994 A-197
060 10 $aWM 270$bB6156 1993
074 $a1070-M
074 $a1070-M (online)
082 00 $a616.86$220
086 0 $aY 3.T 22/2:2 B 52/9
088 $aOTA-BP-BBS-117
245 00 $aBiological components of substance abuse and addiction.
260 $aWashington, DC :$bU.S. Congress, Office of Technology Assessment :$bFor sale by the U.S. G.P.O., Supt. of Docs.,$c[1993]
300 $avi, 61 pages :$billustrations ;$c26 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aBackground paper
500 $aShipping list no.: 1993-0624-P.
500 $a"September 1993"--T.p. verso.
504 $aIncludes bibliographical references.
500 $a"OTA-BP-BBS-117"--P. [4] of cover.
530 $aAlso available via Internet from the UNT Cybercemetery web site. Address as of 2/12/2003: http://govinfo.library.unt.edu/ota/Ota1/DATA/1993/9311.PDF; current access available via PURL.
650 0 $aSubstance abuse$zUnited States.$0http://id.loc.gov/authorities/subjects/sh2010113419
650 0 $aDrug abuse$zUnited States.$0http://id.loc.gov/authorities/subjects/sh2008117531
650 0 $aDrug addiction$zUnited States.$0http://id.loc.gov/authorities/subjects/sh2009123880
650 0 $aBrain$xEffect of drugs on.$0http://id.loc.gov/authorities/subjects/sh2009117513
650 0 $aPsychobiology.$0http://id.loc.gov/authorities/subjects/sh85108425
650 0 $aDrug addiction$xPhysiological aspects.
650 0 $aDrug addiction$xGenetic aspects.
650 12 $aSubstance-Related Disorders$xetiology.$0https://id.nlm.nih.gov/mesh/D019966Q000209
650 22 $aSubstance-Related Disorders$xgenetics.$0https://id.nlm.nih.gov/mesh/D019966Q000235
650 22 $aPsychotropic Drugs$xpharmacology.$0https://id.nlm.nih.gov/mesh/D011619Q000494
650 22 $aBrain$xdrug effects.$0https://id.nlm.nih.gov/mesh/D001921Q000187
710 1 $aUnited States.$bCongress.$bOffice of Technology Assessment.$0http://id.loc.gov/authorities/names/n79006671
830 0 $aBackground paper (United States. Congress. Office of Technology Assessment)
856 41 $uhttp://purl.access.gpo.gov/GPO/LPS26798
852 30 $boff,docs$hY 3.T 22/2:2 B 52/9